Genalyte

Genalyte Launches MT-ADA Assay for Detecting Anti-Drug Antibodies

The medical device and pharmaceutical firm has introduced aan assay designed to run on the Maverick detection system.

Genalyte, Inc. today announced the launch of its MT-ADA anti-drug antibody (ADA) immunogenicity assay designed to run on the Maverick Detection System.  This test combines screening for the presence of ADAs and the characterization of each detected ADA with a full isotype profile.  With minimal required sample preparation and its combination of detection and characterization in a single assay, the MT-ADA assay streamlines ADA testing for both mouse and human samples, providing real-time detection without the use of dyes, fluorescent probes or radioactive labels.

No votes yet

Genalyte Launches MT-ADA Assay for Detecting Anti-Drug Antibodies

The medical device and pharmaceutical firm has introduced aan assay designed to run on the Maverick detection system.

Genalyte, Inc. today announced the launch of its MT-ADA anti-drug antibody (ADA) immunogenicity assay designed to run on the Maverick Detection System.  This test combines screening for the presence of ADAs and the characterization of each detected ADA with a full isotype profile.  With minimal required sample preparation and its combination of detection and characterization in a single assay, the MT-ADA assay streamlines ADA testing for both mouse and human samples, providing real-time detection without the use of dyes, fluorescent probes or radioactive labels.

No votes yet
Syndicate content